moclobemide has been researched along with Sleep Apnea Syndromes in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, FU | 1 |
| Hösch, H | 1 |
| Seibert, H | 1 |
| Klug, R | 1 |
| Köppler, D | 1 |
| Jäger, M | 1 |
1 other study available for moclobemide and Sleep Apnea Syndromes
| Article | Year |
|---|---|
[Obstructive sleep apnoea syndrome as the cause of atypical depression].
Topics: Adult; Antidepressive Agents; Body Weight; Continuous Positive Airway Pressure; Depressive Disorder; | 2011 |